Literature DB >> 2382245

Prospective study of mycobacterial infections in patients with cystic fibrosis.

L Hjelte1, B Petrini, G Källenius, B Strandvik.   

Abstract

Fifty four patients with cystic fibrosis, aged 3-67 years, were studied prospectively for pulmonary mycobacterial infection. Sputum smears and cultures were carried out and intradermal skin tests performed. Mycobacteria were cultured from six patients in association with clinical deterioration; four patients had positive direct smears. Mycobacterium tuberculosis, M aviumintracellulare, M kansasii, and M gordonae were isolated. There were no deaths and all improved with chemotherapy. A third of the other 48 patients had positive skin test responses (greater than 6 mm) to purified protein derivative (PPD) tuberculin and 21 to one or more antigens prepared from non-tuberculous mycobacteria. Sensitisation increased with age; before the age of 11 only one patient had a positive response to PPD tuberculin and none to any other antigen. This was less than in healthy control subjects of similar age. After age 11 the reactions in sensitised patients were stronger than in positive healthy control subjects. Our study indicates that it is important to consider mycobacterial infection in patients with cystic fibrosis who deteriorate without obvious cause.

Entities:  

Mesh:

Year:  1990        PMID: 2382245      PMCID: PMC462488          DOI: 10.1136/thx.45.5.397

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.

Authors:  J Carlstedt-Duke; M Brönnegård; B Strandvik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Sensitivity to tuberculin and sensitins in Swedish children.

Authors:  A Lind; M W Bentzon; I M Doshee; B Graf; M Jonsson; L O Larsson; B M Lindestad; M Magnusson; J Olofson; I Sjogren
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1988-12

4.  Mycobacterium gordonae in the acquired immunodeficiency syndrome.

Authors:  J Chan; J C McKitrick; R S Klein
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

5.  Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis.

Authors:  J Efthimiou; M J Smith; M E Hodson; J C Batten
Journal:  Br J Dis Chest       Date:  1984-07

6.  Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.

Authors:  J T Zakrzewski; N C Barnes; P J Piper; J F Costello
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

7.  Mycobacterial isolations in young adults with cystic fibrosis.

Authors:  M J Smith; J Efthimiou; M E Hodson; J C Batten
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

8.  Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency.

Authors:  V Rogiers; A Vercruysse; I Dab; D Baran
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

Review 9.  Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects.

Authors:  G L Woods; J A Washington
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

10.  The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates.

Authors:  A M Margileth
Journal:  Pediatr Infect Dis       Date:  1983 May-Jun
View more
  25 in total

1.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Authors:  Stacey L Martiniano; Marci K Sontag; Charles L Daley; Jerry A Nick; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Evaluating candidate agents of selective pressure for cystic fibrosis.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  J R Soc Interface       Date:  2007-02-22       Impact factor: 4.118

Review 4.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

5.  Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.

Authors:  Bodil E Jönsson; Marita Gilljam; Anders Lindblad; Malin Ridell; Agnes E Wold; Christina Welinder-Olsson
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

Review 6.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 7.  Is bronchoscopy an obsolete tool in cystic fibrosis? The role of bronchoscopy in cystic fibrosis and its clinical use.

Authors:  Lisa Paul
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 8.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

9.  Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.

Authors:  S Whittier; R L Hopfer; M R Knowles; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Authors:  Anne-Laure Roux; Emilie Catherinot; Fabienne Ripoll; Nathalie Soismier; Edouard Macheras; Sophie Ravilly; Gil Bellis; Marie-Anne Vibet; Evelyne Le Roux; Lydie Lemonnier; Cristina Gutierrez; Véronique Vincent; Brigitte Fauroux; Martin Rottman; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.